Rep. Carol Miller discloses spouse's sale of stock in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp, with a total value between $60,004 and $200,000.
- Filer
- Hon. Carol Devine Miller (WV)
- Transactions
- 4 across 3 companies
- Direction
- 0 bought · 4 sold
- Notification date
- 04/11/2025
4 transactions in this filing
| Company | Ticker | Type | Amount | Date |
|---|---|---|---|---|
| U.S. Bancorp Common Stock (USB) | USB | Sale | $15,001 - $50,000 | 03/10/2025 |
| PFIZER INC | PFE | Sale | $15,001 - $50,000 | 2025-03-10 |
and 2 more transactions in this filing
In an amended Periodic Transaction Report filed on April 11, 2025, Rep. Carol Devine Miller disclosed four stock sales conducted by her spouse. All transactions occurred on March 10, 2025.
The sales involved common stock in four publicly traded companies: Pfizer, Inc. (PFE), Quest Diagnostics Incorporated (DGX), Target Corporation (TGT), and U.S. Bancorp (USB). Each of these sales was valued in the range of $15,001 to $50,000.
Cumulatively, the total value of the disclosed sales is between $60,004 and $200,000. According to the filing, the assets were held in a United Bank Brokerage Account owned by the spouse. The report did not indicate whether any of the transactions resulted in capital gains exceeding $200.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.